APA (7th ed.) Citation

S, K., B, L., JJ, A., SW, C., D, B., D, Q., . . . R, K. (2022). Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting. Oncoimmunology, 11(1), 2052410. https://doi.org/10.1080/2162402X.2022.2052410

Chicago Style (17th ed.) Citation

S, Kato, et al. "Serial Changes in Liquid Biopsy-derived Variant Allele Frequency Predict Immune Checkpoint Inhibitor Responsiveness in the Pan-cancer Setting." Oncoimmunology 11, no. 1 (2022): 2052410. https://doi.org/10.1080/2162402X.2022.2052410.

MLA (9th ed.) Citation

S, Kato, et al. "Serial Changes in Liquid Biopsy-derived Variant Allele Frequency Predict Immune Checkpoint Inhibitor Responsiveness in the Pan-cancer Setting." Oncoimmunology, vol. 11, no. 1, 2022, p. 2052410, https://doi.org/10.1080/2162402X.2022.2052410.